Abstract
Primary sclerosing cholangitis is a chronic, progressive disease of inflammation and fibrosis of the bile ducts. The ability to predict survival is important for appropriate management and treatment decisions. The purpose of this study was to examine the relationship between specific findings on the enhanced magnetic resonance imaging (MRI) examination of the liver and the corresponding magnetic resonance cholangiopancreatogram (MRCP) and a survival model for primary sclerosing cholangitis (PSC), the Mayo Risk Score. During a five-year period, 47 patients with primary sclerosing cholangitis were identified who had a complete MRI/MRCP examination. The extent of anatomical changes of the biliary tree and the degree of peribiliary enhancement in the hepatic parenchyma were compared with the Mayo Risk Score for each patient. Peribiliary enhancement was present to a varying extent in 38 of 47 cases of PSC. Peribiliary enhancement 3 min after gadolinium administration had a weak correlation with the Mayo Risk Score (analysis of variance P < 0.01, Pearson correlation r = 0.37). No statistically significant relationship between the severity of extrahepatic or intrahepatic duct changes and the Mayo Risk Score was found (analysis of variance P = 0.24, P = 0.38, respectively). Although biliary tree changes on MRCP aid in the diagnosis of PSC, they do not correlate with survival, as predicted by the Mayo Risk Score. Peribiliary enhancement on MRI of the liver is a finding occurring to a variable extent in primary sclerosing cholangitis but does not correlate significantly with survival.
Similar content being viewed by others
References
Ludwig J, Barham SS, LaRusso NF, Elveback LR, Wiesner RH, McCall JT (1981) Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1:632–640
Wiesner RH, LaRusso NF (1980) Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 79:200–206
Vitellas KM, Keogan MT, Freed KS, Enns RA, Spitzer CE, Baillie J, Nelson RC (2000) Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiography. Radiographics 20:959–975
Nakanuma Y, Harada K, Katayanagi K, Tsuneyama K, Sasaki M (1999) Definition and pathology of primary sclerosing cholangitis. J Hepatobiliary Pancreat Surg 6:333– 342
Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, Fleming TR, Fisher LD, Beaver SJ, LaRusso NF (1989) Primary sclerosing cholangitis: natural history, prognostic factors, and survival analysis. Hepatology 10:430–436
Ernst O, Asselah T, Sergent G, Calvo M, Talbodec N, Paris JC, L’Hermine C (1998) MR cholangiography in primary sclerosing cholangitis. AJR Am J Roentgenol 171:1027–1030
Fulcher AS, Turner MA, Franklin KJ, Shiffman ML, Sterling RK, Luketic VA, Sanyal AJ (2000) Primary sclerosing cholangitis: evaluation with MR cholangiography: a case-control study. Radiology 215:71–80
Craig DA, MacCarty RL, Wiesner RH, Grambsch PM, LaRusso NF (1991) Primary sclerosing cholangitis: value of cholangiography in determining the prognosis. AJR Am J Roentgenol 5:959–964
Ponsioen CT, Vrouenaraets SM, Prawirodirdjo W, Rajaram R, Rauws EA, Mulder CJ, Reitsma JB, Heisterkamp SH, Tytgat GN (2002) Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut 51:562–566
Berstad AE, Aabakken L, Smith HJ, Aasen S, Boberg KM, Schrumpf E (2006) Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis. Clin Gastroenterol Hepatol 4(4):514–520
Kim WR, Therneau TM, Wiesner RH, Poterucha JJ, Benson JT, Malinchoc M, LaRusso NF, Lindor KD, Dickson ER (2000) A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc 75:688–694
Kim WR, Dickson ER (2000) The revised natural history model for primary sclerosing cholangitis. Available at: http:// www.mayoclinic.org/girst/mayomodel3.html. Accessed October 1, 2003
Christensen M, Matzen P, Schulze S, Rosenberg J (2004) Complications of ERCP: a prospective study. Gastrointest Endosc 60(5):721–731
Mallery JS, Baron TH, Dominitz JA, Goldstein JL, Hirota WK, Jacobson BC, Leighton JA, Raddawi HM, Varg JJ 2nd, Waring JP, Fanelli RD, Wheeler-Harbough J, Eisen GM, Faigel DO (2003) Complications of ERCP. Gastrointest Endosc 57(6):633–638
Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, Moore JP, Fennerty MB, Ryan ME, Shaw MJ, Lande JD, Pheley AM (1996) Complications of Endoscopic Biliary Sphincterotomy. N Engl J Med 335:909–919
Bader TR, Veavers KL, Semelka RC (2003) MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease. Radiology 226:675–685
Pugh, RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding esophageal varices. Br J Surg 60:646–649
Child CG, Turcotte J (1964) Surgery and portal hypertension. In: Child CG, ed. The liver and portal hypertension. Philadelphia: Saunders, 1964:50–52
Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864–871
Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D’Amico G, Dickson ER, Kim WR (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33: 464–470
Kim WR, Poterucha JJ, Wiesner RH, LaRusso NF, Lindor KD, Petz J, Therneau TM, Malinchoc M, Dickson ER (1999) The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology 29:1643
Ito K, Mitchell DG, Outwater EK, Blasbalg R (1999) Primary sclerosing cholangitis: MR imaging features. AJR Am J Roentgenol 172:1527–1533
Revelon G, Rashid A, Kawamoto S, Bleumke DA (1999) Primary sclerosing cholangitis: MR imaging findings with pathologic correlation. AJR Am J Roentgenol 172:1037–1042
Bader TR, Braga L, Beavers KL, Semelka RC (2001) MR imaging findings of infectious cholangitis. Magn Reson Imaging 19:781–788
Kanematsu M, Danet MI, Leonardou P, Mastropasqua M, Mosetti MA, Braga L, Woosley JT, Semelka RC (2004) Early heterogeneous enhancement of the liver: magnetic resonance imaging findings and clinical significance. J Magn Reson Imaging 20:242–249
Harrison RF, Hubscher SG (1991) The spectrum of bile duct lesions in end-stage primary sclerosing cholangitis. Histopathology 19:321–327
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Petrovic, B.D., Nikolaidis, P., Hammond, N.A. et al. Correlation Between Findings on MRCP and Gadolinium-Enhanced MR of the Liver and a Survival Model for Primary Sclerosing Cholangitis. Dig Dis Sci 52, 3499–3506 (2007). https://doi.org/10.1007/s10620-006-9720-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-006-9720-1